Company intelligence / Profile preview

Euro Nippon Kajaku

Munich, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Euro Nippon Kayaku is the European subsidiary of the Japanese conglomerate Nippon Kayaku, focusing on the marketing and distribution of pharmaceutical products and specialty chemicals. The company's pharmaceutical portfolio is primarily centered on oncology, offering a range of generic and biosimilar products for various cancer types. In addition to its healthcare activities, the company provides chemical products for industries such as automotive safety and functional resins. Euro Nippon Kayaku serves as a strategic hub for the parent company's expansion and regulatory compliance within the European market.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyBiosimilar
Industry: Biotech

Beyond the preview

Go deeper on Euro Nippon Kajaku.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Euro Nippon Kajaku.

Explore the full profile